# Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome

> **NCT01391481** · PHASE2 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Respiratory Distress Syndrome, Adult
- Acute Lung Injury

## Interventions

- **DRUG:** Perfluorocarbon
- **DRUG:** Sterile Water for Injection

## Key facts

- **NCT ID:** NCT01391481
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2013-04
- **Final completion:** 2015-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-04-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01391481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01391481, "Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01391481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*